CSIMarket
 


Oramed Pharmaceuticals Inc   (ORMP)
Other Ticker:  
 
 

ORMP's Operating Income Growth by Quarter and Year

Oramed Pharmaceuticals Inc 's Operating Income results by quarter and year




ORMP Operating Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter August - 2.35 3.15 2.85
III Quarter May 2.27 4.08 4.53 2.16
II Quarter February 4.04 3.57 3.11 3.37
I Quarter November 2.43 4.64 2.73 2.40
FY   8.74 14.64 13.52 10.78



ORMP Operating Income third quarter 2020 Y/Y Growth Comment
Oramed Pharmaceuticals Inc reported fall in Operating Income in the third quarter by -44.26% to $ 2.27 millions, from the same quarter in 2019.
The drop in the third quarter Oramed Pharmaceuticals Inc 's Operating Income compares unfavorably to the Company's average Operating Income growth of 0.78%.

Among companies who have reported third quarter results in the Major Pharmaceutical Preparations industry only one Company has achieved higher year on year Operating Income results in the third quarter. While Oramed Pharmaceuticals Inc ' s Operating Income drop of -44.26% ranks overall at the positon no. 114 in the third quarter.

Explain Operating Income growth


ORMP Operating Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter August - -25.4 % 10.53 % -19.49 %
III Quarter May -44.26 % -9.93 % 109.72 % 2.37 %
II Quarter February 13.17 % 14.79 % -7.72 % 76.44 %
I Quarter November -47.63 % 69.96 % 13.75 % -2.04 %
FY   - 8.28 % 25.42 % 7.69 %

Financial Statements
Oramed Pharmaceuticals Inc 's third quarter 2020 Operating Income $ 2.27 millions ORMP's Income Statement
Oramed Pharmaceuticals Inc 's third quarter 2019 Operating Income $ 4.08 millions Quarterly ORMP's Income Statement
New: More ORMP's historic Operating Income Growth >>


ORMP Operating Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter August - -42.4 % -30.46 % 31.94 %
III Quarter May -43.71 % 14.29 % 45.66 % -35.91 %
II Quarter February 66.26 % -23.06 % 13.92 % 40.42 %
I Quarter November 3.4 % 47.3 % -4.21 % -32.2 %
FY (Year on Year)   - 8.28 % 25.42 % 7.69 %




Operating Income third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #8
Overall #114

Operating Income Y/Y Growth Statistics
High Average Low
21.92 % 0.78 % -15.11 %
(May 31 2018)   (Nov 30 2019)
Operating Income third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #8
Overall #114
Operating Income Y/Y Growth Statistics
High Average Low
21.92 % 0.78 % -15.11 %
(May 31 2018)   (Nov 30 2019)

Operating Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Oramed Pharmaceuticals Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
72.15 % 4.1 % -100 %
(Feb 28 2013)  


ORMP's III. Quarter Q/Q Operating Income Comment
In the III. Quarter 2020 Oramed Pharmaceuticals Inc realized fall in Operating Income from the previous quarter by -43.71% to $ 2.27 millions, from $ 4.04 millions declared a quarter before.

Even periodic circumstance which commonly elevate III. Quarter 2020 performance, that clearly has not been sufficient to recover Major Pharmaceutical Preparations's company III. Quarter 2020 outcome, Mario Gutiérrez, Healthcare sector expert allocated in Barcelona said.

Within Major Pharmaceutical Preparations industry only one company achieved higher sequential Operating Income growth. While Oramed Pharmaceuticals Inc 's Operating Income growth quarter on quarter, overall rank is 107.


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #7
Overall #107
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #2
Healthcare Sector #7
Overall #107
Operating Income Q/Q Growth Statistics
High Average Low
72.15 % 4.1 % -100 %
(Feb 28 2013)  


ORMP's III. Quarter Q/Q Operating Income Comment
In the III. Quarter 2020 Oramed Pharmaceuticals Inc realized fall in Operating Income from the second quarter by -43.71% to $ 2.27 millions, from $ 4.04 millions released in the previous reporting period.

Those cyclical influence were not able to recover the III. Quarter for the Oramed Pharmaceuticals Inc , Mario Gutiérrez, Healthcare sector expert allocated in Barcelona wrote, he cited certan caution towards ORMP's direction and wrote that average quarter on quarter Operating Income growth is at 4.1% for Oramed Pharmaceuticals Inc .

Within Major Pharmaceutical Preparations industry only one company achieved higher sequential Operating Income growth. While Oramed Pharmaceuticals Inc 's Operating Income growth quarter on quarter, overall rank is 107.


Oramed Pharmaceuticals Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(May 31 2020)
12 Months Ending
(Feb 29 2020)
12 Months Ending
(Nov 30 2019)
12 Months Ending
(Aug 31 2019)
12 Months Ending
(May 31 2019)
Cumulative Operating Income 12 Months Ending $ 11.09 $ 12.89 $ 12.42 $ 14.63 $ 15.44
Y / Y Operating Income Growth (TTM) -28.19 % -18.9 % -19.53 % 8.16 % 16.67 %
Year on Year Operating Income Growth Overall Ranking # 111 # 38 # 37 # 828 # 715
Seqeuential Operating Income Change (TTM) -14 % 3.78 % -15.11 % -5.22 % -2.87 %
Seq. Operating Income Growth (TTM) Overall Ranking # 1333 # 654 # 2176 # 1959 # 1823




Cumulative Operating Income growth Comment
Oramed Pharmaceuticals Inc 's cumulative 12 months Operating Income continue to drop, but on the faster rate at -28.19% year on year, at May 31 2020 compare to the -18.9% decrease at Feb 29 2020. If the Oramed Pharmaceuticals Inc 's fiscal year would end at May 31 2020, annual Operating Income would be $11 millions.

Among companies within the Healthcare sector 9 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 38 to 111.

Operating Income TTM Q/Q Growth Statistics
High Average Low
21.92 %
0.78 %
-15.11 %
(May 31 2018)  

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 2
Healthcare Sector # 10
Overall # 111

Operating Income TTM Y/Y Growth Statistics
High Average Low
46.46 %
8.3 %
-28.19 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 95
S&P 500 # 1326
Cumulative Operating Income growth Comment
Oramed Pharmaceuticals Inc 's cumulative 12 months Operating Income continue to drop, but on the faster rate at -28.19% year on year, at May 31 2020 compare to the -18.9% decrease at Feb 29 2020. If the Oramed Pharmaceuticals Inc 's fiscal year would end at May 31 2020, annual Operating Income would be $11 millions.

Among companies within the Healthcare sector 9 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 38 to 111.

Operating Income TTM Q/Q Growth Statistics
High Average Low
21.92 %
0.78 %
-15.11 %
(May 31 2018)  


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 2
Healthcare Sector # 10
Overall # 111

Operating Income TTM Y/Y Growth Statistics
High Average Low
46.46 %
8.3 %
-28.19 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 25
Sector # 95
S&P 500 # 1326




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
ORMP's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for ORMP's Competitors
Operating Income Growth for Oramed Pharmaceuticals Inc 's Suppliers
Operating Income Growth for ORMP's Customers

You may also want to know
ORMP's Annual Growth Rates ORMP's Profitability Ratios ORMP's Asset Turnover Ratio ORMP's Dividend Growth
ORMP's Roe ORMP's Valuation Ratios ORMP's Financial Strength Ratios ORMP's Dividend Payout Ratio
ORMP's Roa ORMP's Inventory Turnover Ratio ORMP's Growth Rates ORMP's Dividend Comparisons



Companies with similar Operating Income drop for the quarter ending May 31 2020 within Healthcare SectorY/Y Change %Operating Income for the quarter ending May 31 2020
Oramed Pharmaceuticals Inc -44.24 %$ -44.237 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

OSTK's Profile

Stock Price

OSTK's Financials

Business Description

Fundamentals

Charts & Quotes

OSTK's News

Suppliers

OSTK's Competitors

Customers & Markets

Economic Indicators

OSTK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071